Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Question· writtenPQ 1873asked
Ireland · Dáil Éireann · 9 June 2026
1873. Deputy Duncan Smith asked the Minister for Health the steps being taken to amend the Children and Family Relationships Act 2015 to provide for the recognition in Ireland of intended parents of children born abroad through lawful donor assisted reproduction arrangements, in line with Constitutional equality principles and the best interests of the child; and if she will make a statement on the matter. [41819/26]
Question· writtenPQ 1872asked
Ireland · Dáil Éireann · 9 June 2026
1872. Deputy Duncan Smith asked the Minister for Health whether she has examined the implications of the Children and Family Relationships Act 2015 for Irish citizens who become parents through lawful assisted reproduction abroad; if she accepts that the current legislation may leave children born in such circumstances without legal protections under Irish law; and if she will make a statement on the matter. [41818/26]
Question· writtenPQ 1871asked
Ireland · Dáil Éireann · 9 June 2026
1871. Deputy Roderic O'Gorman asked the Minister for Health for a timeline on the skyclarys reimbursement negotiations, following the submission of a proposal by an organisation (details supplied) to the HSE's Corporate Pharmaceutical Unit; and if she will make a statement on the matter. [41813/26]
Question· writtenPQ 1863asked
Ireland · Dáil Éireann · 9 June 2026
1863. Deputy Duncan Smith asked the Minister for Health if she is aware that the Donabate Health Centre has 2.5 public health nurses working in the centre to support a current population close to 15,000 which will surpass 20,000 in two years time; will she acknowledge that additional resources are urgently required to ensure the growing Donabate community has sufficient resources to provide supports to the growing community with a standalone primary care centre also urgently needed to support this rapidly growing community; and if she will make a statement on the matter. [41771/26]
Question· writtenPQ 1862asked
Ireland · Dáil Éireann · 9 June 2026
1862. Deputy Colm Burke asked the Minister for Health the steps Ireland will take during its Presidency of the Council of the EU to support improved access across Europe to HIV prevention tools, including testing, PrEP, community-led services and stigma-free care; and if she will make a statement on the matter. [41769/26]
Question· writtenPQ 1861asked
Ireland · Dáil Éireann · 9 June 2026
1861. Deputy Colm Burke asked the Minister for Health whether Ireland will support the development of a renewed EU HIV/AIDS Action Plan, given that the previous EU action plan lapsed in 2016; and whether this issue will be raised during Ireland’s Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration. [41768/26]
Question· writtenPQ 1860asked
Ireland · Dáil Éireann · 9 June 2026
1860. Deputy Colm Burke asked the Minister for Health whether HIV prevention will be considered as part of Ireland’s health priorities during its Presidency of the Council of the EU in 2026, building on the legacy of the 2004 Presidency’s Dublin Declaration, particularly in the context of the EU-wide goal of ending HIV as a public health threat by 2030; and if she will make a statement on the matter. [41767/26]
Question· writtenPQ 1859asked
Ireland · Dáil Éireann · 9 June 2026
1859. Deputy Colm Burke asked the Minister for Health whether she intends to use Ireland’s Presidency of the Council of the EU in 2026 to advance a renewed EU-level political commitment on HIV prevention, building on the legacy of the Dublin Declaration of 2004; and if she will make a statement on the matter. [41766/26]
Question· writtenPQ 1858asked
Ireland · Dáil Éireann · 9 June 2026
1858. Deputy Sorca Clarke asked the Minister for Health the number and location of SATUs currently operating in each county, in tabular form; and if she will make a statement on the matter. [41765/26]
Question· writtenPQ 1857asked
Ireland · Dáil Éireann · 9 June 2026
1857. Deputy Ken O'Flynn asked the Minister for Health whether all categories of treatment funded under the treatment abroad scheme are subject to identical governance, evidential, audit, and approval standards; and if any category-specific governance arrangements exist. [41764/26]
Question· writtenPQ 1856asked
Ireland · Dáil Éireann · 9 June 2026
1856. Deputy Ken O'Flynn asked the Minister for Health whether treatment abroad scheme approval decisions are subject to secondary review, peer review, multidisciplinary review, or independent oversight before final authorisation is granted. [41763/26]
Question· writtenPQ 1855asked
Ireland · Dáil Éireann · 9 June 2026
1855. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains written evidential thresholds or documentary standards required before prior authorisation may be approved under the treatment abroad scheme; and if they will provide details. [41762/26]
Question· writtenPQ 1854asked
Ireland · Dáil Éireann · 9 June 2026
1854. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, clinical governance review, or value-for-money review has examined treatment abroad scheme eligibility decision-making processes since 2020; and if so, to provide details and publication status. [41761/26]
Question· writtenPQ 1853asked
Ireland · Dáil Éireann · 9 June 2026
1853. Deputy Ken O'Flynn asked the Minister for Health whether any formal mechanism exists within the treatment abroad scheme to ensure consistency of eligibility decisions between applicants presenting with comparable clinical circumstances; and if they will outline that mechanism. [41760/26]
Question· writtenPQ 1852asked
Ireland · Dáil Éireann · 9 June 2026
1852. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any internal operational guidance, assessment template, decision-support document, evidential framework, or staff instruction document used in practice when determining eligibility under the treatment abroad scheme; and if so, if copies will be provided. [41759/26]
Question· writtenPQ 1848asked
Ireland · Dáil Éireann · 9 June 2026
1848. Deputy Seán Crowe asked the Minister for Health the number of properties that are in use for the provision of children’s respite services in the CHO7 area each year for the past five years, in tabular form. [41733/26]
Question· writtenPQ 1847asked
Ireland · Dáil Éireann · 9 June 2026
1847. Deputy Seán Crowe asked the Minister for Health the number of WTEs in children’s respite services in the CHO7 area each year for the past five years, in tabular form. [41732/26]
Question· writtenPQ 1845asked
Ireland · Dáil Éireann · 9 June 2026
1845. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the projected number of adolescent patients who could potentially meet the proposed reimbursement criteria for semaglutide. [41718/26]
Question· writtenPQ 1843asked
Ireland · Dáil Éireann · 9 June 2026
1843. Deputy Ken O'Flynn asked the Minister for Health whether any assessment has been undertaken of the long-term fiscal sustainability of reimbursing GLP-1 and dual agonist obesity therapies within the public health system. [41716/26]
Question· writtenPQ 1842asked
Ireland · Dáil Éireann · 9 June 2026
1842. Deputy Ken O'Flynn asked the Minister for Health whether multidisciplinary assessment, psychological screening, or behavioural intervention participation will be mandatory prior to reimbursement approval for obesity pharmacotherapies. [41715/26]
Question· writtenPQ 1841asked
Ireland · Dáil Éireann · 9 June 2026
1841. Deputy Ken O'Flynn asked the Minister for Health whether any national eligibility framework, prioritisation framework, or phased access model is under development for obesity pharmacotherapy reimbursement. [41714/26]
Question· writtenPQ 1840asked
Ireland · Dáil Éireann · 9 June 2026
1840. Deputy Ken O'Flynn asked the Minister for Health whether any estimate has been produced of the potential annual Exchequer cost associated with reimbursement of obesity pharmacotherapies under current licensing criteria. [41713/26]
Question· writtenPQ 1839asked
Ireland · Dáil Éireann · 9 June 2026
1839. Deputy Ken O'Flynn asked the Minister for Health whether the Department or HSE has undertaken any modelling of the projected annual eligible population for reimbursement of tirzepatide or semaglutide for obesity treatment over the next five years. [41712/26]
Question· writtenPQ 1826asked
Ireland · Dáil Éireann · 9 June 2026
1826. Deputy Ken O'Flynn asked the Minister for Health the number of Irish-trained healthcare professionals who emigrated or took up employment outside the State in each year since 2020, insofar as figures are available. [41693/26]
Question· writtenPQ 1821asked
Ireland · Dáil Éireann · 9 June 2026
1821. Deputy Ken O'Flynn asked the Minister for Health whether documentary records exist including minutes, memoranda, briefing papers, internal correspondence, emails, governance submissions, or evidential assessments concerning the inclusion of WPATH Standards of Care references within the 2019 CAAC application; and whether such records will be retained under HSE records management and governance procedures. [41688/26]
Question· writtenPQ 1819asked
Ireland · Dáil Éireann · 9 June 2026
1819. Deputy Ken O'Flynn asked the Minister for Health to identify the specific HSE national clinical governance structure, committee, officeholder, or decision-making body responsible for approving or overseeing the inclusion of WPATH Standards of Care references within the 2019 CAAC application relating to the proposed consultant child and adolescent psychiatry post for specialist gender healthcare services. [41686/26]
Question· writtenPQ 1814asked
Ireland · Dáil Éireann · 9 June 2026
1814. Deputy Ken O'Flynn asked the Minister for Health whether any national audit, review, inspection, governance assessment, or external evaluation has been undertaken in relation to gender-related healthcare pathways involving minors within the State; and if they will provide details of the findings and recommendations. [41671/26]
Question· writtenPQ 1813asked
Ireland · Dáil Éireann · 9 June 2026
1813. Deputy Ken O'Flynn asked the Minister for Health whether they are satisfied that the current capacity within autism assessment services, ADHD assessment services, CAMHS, child psychology services, trauma-informed services, and multidisciplinary child mental health supports is sufficient to ensure that minors presenting with gender-related distress receive timely and holistic assessment of all co-occurring needs prior to progression within gender-related healthcare pathways. [41670/26]
Question· writtenPQ 1812asked
Ireland · Dáil Éireann · 9 June 2026
1812. Deputy Ken O'Flynn asked the Minister for Health whether international evidence reviews relating to youth gender-related healthcare, including reviews examining neurodevelopmental comorbidity, multidisciplinary assessment, safeguarding, and holistic care models, have informed the development of Irish policy, governance structures, or service models in this area; and if they will specify the reviews considered. [41669/26]
Question· writtenPQ 1811asked
Ireland · Dáil Éireann · 9 June 2026
1811. Deputy Ken O'Flynn asked the Minister for Health whether her Department, the HSE, or any State-funded body has commissioned, conducted, or reviewed Irish epidemiological, clinical, or service-level research concerning the prevalence of autism spectrum disorder, ADHD, trauma-related conditions, mental health comorbidities, or other neurodevelopmental vulnerabilities among minors presenting with gender-related distress; and if they will provide details of any such work. [41668/26]
Question· writtenPQ 1810asked
Ireland · Dáil Éireann · 9 June 2026
1810. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any longitudinal outcome-monitoring framework relating to minors who access gender-related healthcare pathways, including continuation or discontinuation of treatment pathways, mental health outcomes, safeguarding concerns, ongoing service engagement, or transition between child and adult services; and if they will provide details. [41667/26]
Question· writtenPQ 1808asked
Ireland · Dáil Éireann · 9 June 2026
1808. Deputy Ken O'Flynn asked the Minister for Health whether Children First obligations, safeguarding frameworks, or specific child protection procedures form part of the operational governance framework for minors presenting to gender-related healthcare pathways; and if they will provide details. [41665/26]
Question· writtenPQ 1807asked
Ireland · Dáil Éireann · 9 June 2026
1807. Deputy Ken O'Flynn asked the Minister for Health the national clinical governance framework currently applies to gender-related healthcare services involving minors, including governance arrangements relating to multidisciplinary review, clinical decision-making, safeguarding oversight, escalation procedures, audit arrangements, and oversight by the HSE or her Department. [41664/26]
Question· writtenPQ 1806asked
Ireland · Dáil Éireann · 9 June 2026
1806. Deputy Ken O'Flynn asked the Minister for Health the multidisciplinary assessment requirements currently apply within the HSE or any State-funded gender-related healthcare pathway for minors, including the involvement of psychiatry, psychology, paediatrics, neurodevelopmental services, social work, family assessment, and safeguarding oversight.; and if she will make a statement on the matter. [41663/26]
Question· writtenPQ 1804asked
Ireland · Dáil Éireann · 9 June 2026
1804. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records data regarding minors presenting to gender-related healthcare pathways who are awaiting autism assessment, ADHD assessment, CAMHS intervention, or other specialist neurodevelopmental or mental health assessment at the time of referral; and if they will provide details. [41661/26]
Question· writtenPQ 1803asked
Ireland · Dáil Éireann · 9 June 2026
1803. Deputy Ken O'Flynn asked the Minister for Health whether the HSE records the number or proportion of minors presenting to gender-related healthcare pathways who have a diagnosed autism spectrum disorder, diagnosed ADHD, diagnosed anxiety disorder, diagnosed depressive disorder, diagnosed trauma-related condition, or other identified neurodevelopmental or mental health comorbidity; and if they will provide the available figures for each of the past five years. [41660/26]
Question· writtenPQ 1802asked
Ireland · Dáil Éireann · 9 June 2026
1802. Deputy Ken O'Flynn asked the Minister for Health whether the HSE or any State-funded service currently collects national data relating to minors presenting to gender-related healthcare pathways, including age profile, biological sex, referral source, and whether co-occurring neurodevelopmental, mental health, trauma-related, or safeguarding concerns are recorded; and if they will provide details of the datasets currently maintained. [41659/26]
Question· writtenPQ 1789asked
Ireland · Dáil Éireann · 9 June 2026
1789. Deputy Pádraig O'Sullivan asked the Minister for Health whether current maternity workforce planning models fully account for increasing clinical complexity rather than birth numbers alone; and if she will make a statement on the matter. [41617/26]
Question· writtenPQ 1788asked
Ireland · Dáil Éireann · 9 June 2026
1788. Deputy Pádraig O'Sullivan asked the Minister for Health the steps being taken to ensure equitable access to community midwifery, specialist supports and continuity-of-care models across all regions; and if she will make a statement on the matter. [41616/26]
Question· writtenPQ 1785asked
Ireland · Dáil Éireann · 9 June 2026
1785. Deputy Seán Ó Fearghaíl asked the Minister for Health if she will confirm that the Government will continue the provision of the respiratory syncytial virus vaccination programme for all eligible infants on a free-of-charge basis, notwithstanding the recent HIQA report raising concerns regarding cost-effectiveness; if she has assessed the impact of the programme in reducing infant hospitalisations and pressure on paediatric services; and if she will make a statement on the matter. [41603/26]
Question· writtenPQ 1783asked
Ireland · Dáil Éireann · 9 June 2026
1783. Deputy Natasha Newsome Drennan asked the Minister for Health the current status of the AMRIC antimicrobial resistance programme; if the programme has been reviewed and updated following the concerns raised by the EU Commission over the Antibiotic/Anti-Microbial Resistance (AMR) threat posed by Brazilian beef production; and if she will make a statement on the matter. [41597/26]
Question· writtenPQ 1780asked
Ireland · Dáil Éireann · 9 June 2026
1780. Deputy Sorca Clarke asked the Minister for Health the status of primary care centre developments in Longford and Westmeath, including any planned expansions or new facilities; the expected timelines for delivery; and if she will make a statement on the matter. [41542/26]
Question· writtenPQ 1778asked
Ireland · Dáil Éireann · 9 June 2026
1778. Deputy Sorca Clarke asked the Minister for Health the level of funding allocated to primary care services in Longford and Westmeath in each of the past five years; the additional resources provided in 2026; and if she will make a statement on the matter. [41540/26]
Question· writtenPQ 1764asked
Ireland · Dáil Éireann · 9 June 2026
1764. Deputy Shane Moynihan asked the Minister for Health the way in which the HSE's current child vision screening and follow-up pathways account for the onset of myopia in children typically occurring between the ages of 8 and 16 given that children are discharged from public eye care services at age 8 if no issues are identified at that point; whether she has considered extending screening or follow-up supports beyond this age range in light of projections that up to 50% of the global population may be myopic by 2050; and if she will make a statement on the matter. [41520/26]
Question· writtenPQ 1763asked
Ireland · Dáil Éireann · 9 June 2026
1763. Deputy Shane Moynihan asked the Minister for Health if she will clarify the position regarding the use of the high index allowance under the HSE's standard letter of approval (LOA/2) voucher for children's optical services; whether this allowance may be used universally towards myopia control lenses, or only in cases where a child meets a defined prescription threshold; and if she will make a statement on the matter. [41519/26]
Question· writtenPQ 1759asked
Ireland · Dáil Éireann · 9 June 2026
1759. Deputy Shane Moynihan asked the Minister for Health the timeline for a decision by the HSE drugs group regarding the reimbursement of risdiplam for adults living with spinal muscular atrophy; and if she will make a statement on the matter. [41498/26]
Question· writtenPQ 1758asked
Ireland · Dáil Éireann · 9 June 2026
1758. Deputy Richard Boyd Barrett asked the Minister for Health the position regarding legislation governing the addition of non-natal parents of children conceived through donor-assisted human reproduction; and where the process was carried out in jurisdictions other than Ireland, to the birth certificate of the child. [41491/26]
Question· writtenPQ 1756asked
Ireland · Dáil Éireann · 9 June 2026
1756. Deputy Conor Sheehan asked the Minister for Health the actions her Department is taking to address the acute national shortage of dental nurses within the oral healthcare sector; if she has engaged with the Minister for Enterprise, Tourism and Employment to support the removal of dental nurses from the ineligible list of occupations to allow for general employment permits; and if she will make a statement on the matter. [41475/26]
Question· writtenPQ 1755asked
Ireland · Dáil Éireann · 9 June 2026
1755. Deputy Barry Heneghan asked the Minister for Health if the medication fezolinetant will be made available under the drug payment scheme for individuals who cannot take HRT as a result of a cancer diagnosis; and if she will make a statement on the matter. [41473/26]
Question· writtenPQ 1746asked
Ireland · Dáil Éireann · 9 June 2026
1746. Deputy Brian Brennan asked the Minister for Health the structural measures she is taking, in coordination with the Minister for Children, Disability and Equality, to compel the HSE and primary care networks to fully transition from an outdated medical model of disability to a human rights-based social model as mandated by Ireland's ratification of the UNCRPD; if she will specifically address the systemic prevalence within primary care where acute neurodivergent burnout is misdiagnosed as neurotypical mental health conditions, such as generalised anxiety disorder or clinical depression; if she acknowledges that these diagnostic errors lead to inappropriate, deficit-based treatment pathways that actively compound psychological trauma and executive function collapse; the steps she will take to establish safe, non-adversarial, and adaptive emergency therapeutic pathways for neurodivergent adults experiencing systemic crises; and if she will make a statement on the matter. [41437/26]
PreviousPage 14 of 15Next